MedTrace Logo

Immunoadsorption in Patients With Pulmonary Hypertension

NCT01126411 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2016-11-16

No results posted yet for this study

Summary

The purpose of this study is to investigate, if Immunoadsorption of autoantibodies with subsequent substitution of immunoglobulins is able to improve haemodynamics in patients with pulmonary hypertension.

Conditions

  • Pulmonary Hypertension
  • Pulmonary Resistance

Interventions

PROCEDURE

immunoadsorption / immunglobulin substitution

Immunoadsorption with protein-A columns on five consecutive days with subsequent human polyclonal immunoglobulin G substitution after day 5 (0,5g /kg bodyweight)

Sponsors & Collaborators

  • University Medicine Greifswald

    lead OTHER

Principal Investigators

  • Ralf Ewert, Prof · University Medicine Greifswald

  • Markus Reinthaler, MD · University Medicine Greifswald

  • Lars R Herda, MD · University Medicine Greifswald

  • Stephan B Felix, Prof. · University Medicine Greifswald

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01126411 on ClinicalTrials.gov